Until now, little was known in
preclinical models about the mechanisms that allow breast cancer cells to leave the latent state and even less is known in patients,» explains Roger Gomis, head of the Growth Control and Cancer Metastasis Lab.
Not exact matches
According to the authors of the study, in future researches it will be necessary to know
about the action mechanism of the new products - highly selective and with low cell toxicity on in vitro tests - and broaden
preclinical studies with laboratory animal
models.